Contributor Disclosures for Goiter, Toxic Nodular

Role Name Disclosure Details Author  Anu Bhalla Davis, MD, Fellow, Department of Internal Medicine, Division of Diabetes, Endocrinology, and Metabolism, University of Texas Health Science Center at Houston Nothing to disclose Details Coauthor  Philip R Orlander, MD, Director of Endocrinology and Metabolism Fellowship, Department of Medicine, Division of Endocrinology, Director, Professor, University of Texas Health Science Center at Houston Nothing to disclose Details Coauthor  Asra Kermani, MBBS, Center for Human Nutrition, Postdoctoral Fellow, University of Texas Southwestern Medical School Nothing to disclose Details Medical Editor  Robert A Gabbay, MD, PhD, Director, Penn State Diabetes Center, Department of Medicine, Associate Professor of Medicine, Hershey Medical Center, Pennsylvania State University Nothing to disclose Details Pharmacy Editor  Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine Nothing to disclose Details Managing Editor  Kent Wehmeier, MD, Professor, Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, St Louis University School of Medicine Nothing to disclose Details CME Editor  Mark Cooper, MD, Head, Vascular Division, Baker Medical Research Institute; Professor of Medicine, Monash University Nothing to disclose Details Chief Editor  George T Griffing, MD, Professor of Medicine, Director of General Internal Medicine, St Louis University Nothing to disclose Details Contributor Disclosure Contributor: Contributor Disclosure: Anu Bhalla Davis, Author  The contributor discloses no conflict of interest.  Contributor Disclosure Contributor: Contributor Disclosure: Philip R Orlander, Coauthor  The contributor discloses no conflict of interest.  Contributor Disclosure Contributor: Contributor Disclosure: Asra Kermani, Coauthor  The contributor discloses no conflict of interest.  Contributor Disclosure Contributor: Contributor Disclosure: Robert A Gabbay, Medical Editor  The contributor discloses no conflict of interest.  CONTRIBUTOR DISCLOSURE FORM Contributor Name: Francisco Talavera  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** Contributor Disclosure Contributor: Contributor Disclosure: Kent Wehmeier, Managing Editor  The contributor discloses no conflict of interest.  CONTRIBUTOR DISCLOSURE FORM Contributor Name: Mark Cooper  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** Off label or investigational use of medication Contributor Disclosure Contributor: Contributor Disclosure: George T Griffing, Chief Editor  The contributor discloses no conflict of interest.